{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apigenin", "bioavailability", "cancer", "cell signalling pathways", "synergistic effects"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36144783", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "16"}], "Language": ["eng"], "ELocationID": ["6051", "10.3390/molecules27186051"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "18", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "16"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "The Potential Role of Apigenin in Cancer Prevention and Treatment.", "Abstract": {"AbstractText": ["Cancer is the leading cause of death worldwide. In spite of advances in the treatment of cancer, currently used treatment modules including chemotherapy, hormone therapy, radiation therapy and targeted therapy causes adverse effects and kills the normal cells. Therefore, the goal of more effective and less side effects-based cancer treatment approaches is still at the primary position of present research. Medicinal plants or their bioactive ingredients act as dynamic sources of drugs due to their having less side effects and also shows the role in reduction of resistance against cancer therapy. Apigenin is an edible plant-derived flavonoid that has received significant scientific consideration for its health-promoting potential through modulation of inflammation, oxidative stress and various other biological activities. Moreover, the anti-cancer potential of apigenin is confirmed through its ability to modulate various cell signalling pathways, including tumor suppressor genes, angiogenesis, apoptosis, cell cycle, inflammation, apoptosis, PI3K/AKT, NF-\u03baB, MAPK/ERK and STAT3 pathways. The current review mainly emphases the potential role of apigenin in different types of cancer through the modulation of various cell signaling pathways. Further studies based on clinical trials are needed to explore the role of apigenin in cancer management and explain the possible potential mechanisms of action in this vista."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Rahmani", "ForeName": "Arshad Husain", "Initials": "AH"}, {"Identifier": ["0000-0001-9357-2216"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Alsahli", "ForeName": "Mohammed A", "Initials": "MA"}, {"Identifier": ["0000-0002-1491-6402"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Almatroudi", "ForeName": "Ahmad", "Initials": "A"}, {"Identifier": ["0000-0002-1043-959X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Almogbel", "ForeName": "Mashael Abdullah", "Initials": "MA"}, {"Identifier": ["0000-0001-6030-4493"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Health Science, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Amjad Ali", "Initials": "AA"}, {"Identifier": ["0000-0003-3448-9353"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Anwar", "ForeName": "Shehwaz", "Initials": "S"}, {"Identifier": ["0000-0002-5260-0265"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Almatroodi", "ForeName": "Saleh A", "Initials": "SA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hormones"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "7V515PI7F6", "NameOfSubstance": "Apigenin"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Apigenin"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hormones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["drug therapy", "prevention & control"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mangal M., Sagar P., Singh H., Raghava G.P., Agarwal S.M. NPACT: Naturally occurring plant-based anti-cancer compound-activitytarget database. Nucleic Acids Res. 2012;41:D1124\u2013D1129. doi: 10.1093/nar/gks1047.", "ArticleIdList": ["10.1093/nar/gks1047", "PMC3531140", "23203877"]}, {"Citation": "Knekt P., Kumpulainen J., J\u00e4rvinen R., Rissanen H., Heli\u00f6vaara M., Reunanen A., Hakulinen T., Aromaa A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002;76:560\u2013568. doi: 10.1093/ajcn/76.3.560.", "ArticleIdList": ["10.1093/ajcn/76.3.560", "12198000"]}, {"Citation": "Manson M.M. Cancer prevention\u2014The potential for diet to modulate molecular signalling. Trends Mol. Med. 2003;9:11\u201318. doi: 10.1016/S1471-4914(02)00002-3.", "ArticleIdList": ["10.1016/S1471-4914(02)00002-3", "12524205"]}, {"Citation": "Cermak R., Wolffram S. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms. Curr. Drug Metab. 2006;7:729\u2013744. doi: 10.2174/138920006778520570.", "ArticleIdList": ["10.2174/138920006778520570", "17073577"]}, {"Citation": "Chen A.Y., Chen Y.C. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013;138:2099\u20132107. doi: 10.1016/j.foodchem.2012.11.139.", "ArticleIdList": ["10.1016/j.foodchem.2012.11.139", "PMC3601579", "23497863"]}, {"Citation": "Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 2001;21:381\u2013406. doi: 10.1146/annurev.nutr.21.1.381.", "ArticleIdList": ["10.1146/annurev.nutr.21.1.381", "11375442"]}, {"Citation": "O\u2019Prey J., Brown J., Fleming J., Harrison P.R. Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochem. Pharmacol. 2003;66:2075\u20132088. doi: 10.1016/j.bcp.2003.07.007.", "ArticleIdList": ["10.1016/j.bcp.2003.07.007", "14609732"]}, {"Citation": "Thiery-Vuillemin A., Nguyen T., Pivot X., Spano J.P., Dufresnne A., Soria J.C. Molecularly targeted agents: Their promise as cancer chemopreventive interventions. Eur. J. Cancer. 2005;41:2003\u20132015. doi: 10.1016/j.ejca.2005.06.005.", "ArticleIdList": ["10.1016/j.ejca.2005.06.005", "16098739"]}, {"Citation": "Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer. 2003;3:768\u2013780. doi: 10.1038/nrc1189.", "ArticleIdList": ["10.1038/nrc1189", "14570043"]}, {"Citation": "Tang K., Chen L., Huang L., Li J. Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. Expert Opin. Drug Metab. Toxicol. 2017;13:323\u2013330. doi: 10.1080/17425255.2017.1251903.", "ArticleIdList": ["10.1080/17425255.2017.1251903", "27766890"]}, {"Citation": "Gupta S., Afaq F., Mukhtar H. Selective Growth-Inhibitory, Cell-Cycle Deregulatory and Apoptotic Response of Apigenin in Normal Versus Human Prostate Carcinoma Cells. Biochem. Biophys. Res. Commun. 2001;87:914\u2013920. doi: 10.1006/bbrc.2001.5672.", "ArticleIdList": ["10.1006/bbrc.2001.5672", "11573952"]}, {"Citation": "Singh P., Mishra S.K., Noel S., Sharma S., Rath S.K. Acute exposure of apigenin induces hepatotoxicity in Swiss mice. PLoS ONE. 2012;7:e31964. doi: 10.1371/journal.pone.0031964.", "ArticleIdList": ["10.1371/journal.pone.0031964", "PMC3281105", "22359648"]}, {"Citation": "Kaur P., Shukla S., Gupta S. Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: An in vitro and in vivo study. Carcinogenesis. 2008;29:2210\u20132217. doi: 10.1093/carcin/bgn201.", "ArticleIdList": ["10.1093/carcin/bgn201", "PMC2577719", "18725386"]}, {"Citation": "Almatroodi S.A., Syed M.A., Rahmani A.H. Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer. Recent Pat. Anticancer Drug Discov. 2021;16:3\u201329. doi: 10.2174/1574892815999201102214602.", "ArticleIdList": ["10.2174/1574892815999201102214602", "33143616"]}, {"Citation": "Almatroudi A., Alsahli M.A., Alrumaihi F., Allemailem K.S., Rahmani A.H. Ginger: A Novel Strategy to Battle Cancer through Modulating Cell Signalling Pathways: A Review. Curr. Pharm. Biotechnol. 2019;20:5\u201316. doi: 10.2174/1389201020666190119142331.", "ArticleIdList": ["10.2174/1389201020666190119142331", "30659535"]}, {"Citation": "Bauer D., Redmon N., Mazzio E., Soliman K.F. Apigenin inhibits TNF\u03b1/IL-1\u03b1-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells. PLoS ONE. 2017;12:e0175558.", "ArticleIdList": ["PMC5404872", "28441391"]}, {"Citation": "Seo H., Sikder M.A., Lee H.J., Ryu J., Lee C.J. Apigenin Inhibits Tumor Necrosis Factor-\u03b1-Induced Production and Gene Expression of Mucin through Regulating Nuclear Factor-Kappa B Signaling Pathway in Airway Epithelial Cells. Biomol. Ther. 2014;22:525\u2013531. doi: 10.4062/biomolther.2014.094.", "ArticleIdList": ["10.4062/biomolther.2014.094", "PMC4256032", "25489420"]}, {"Citation": "Liu R., Ji P., Liu B., Qiao H., Wang X., Zhou L., Ba Y. Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis. Oncol. Lett. 2017;13:1024\u20131030. doi: 10.3892/ol.2016.5495.", "ArticleIdList": ["10.3892/ol.2016.5495", "PMC5351382", "28356995"]}, {"Citation": "Shukla S., Fu P., Gupta S. Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70\u2013Bax interaction in prostate cancer. Apoptosis. 2014;19:883\u2013894. doi: 10.1007/s10495-014-0971-6.", "ArticleIdList": ["10.1007/s10495-014-0971-6", "PMC3997183", "24563225"]}, {"Citation": "Gupta S., Afaq F., Mukhtar H. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene. 2002;21:3727\u20133738. doi: 10.1038/sj.onc.1205474.", "ArticleIdList": ["10.1038/sj.onc.1205474", "12032841"]}, {"Citation": "Liu L.Z., Fang J., Zhou Q., Hu X., Shi X., Jiang B.H. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: Implication of chemoprevention of lung cancer. Mol. Pharmacol. 2005;68:635\u2013643. doi: 10.1124/mol.105.011254.", "ArticleIdList": ["10.1124/mol.105.011254", "15947208"]}, {"Citation": "Osada M., Imaoka S., Funae Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1\u03b1 protein. FEBS Lett. 2004;575:59\u201363. doi: 10.1016/j.febslet.2004.08.036.", "ArticleIdList": ["10.1016/j.febslet.2004.08.036", "15388333"]}, {"Citation": "Meng S., Zhu Y., Li J.F., Wang X., Liang Z., Li S.Q., Xu X., Chen H., Liu B., Zheng X.Y., et al. Apigenin inhibits renal cell carcinoma cell proliferation. Oncotarget. 2017;8:19834\u201319842. doi: 10.18632/oncotarget.15771.", "ArticleIdList": ["10.18632/oncotarget.15771", "PMC5386726", "28423637"]}, {"Citation": "Tseng T.H., Chien M.H., Lin W.L., Wen Y.C., Chow J.M., Chen C.K., Kuo T.C., Lee W.J. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21WAF1/CIP1 expression. Environ. Toxicol. 2017;32:434\u2013444. doi: 10.1002/tox.22247.", "ArticleIdList": ["10.1002/tox.22247", "26872304"]}, {"Citation": "Yang J., Pi C., Wang G. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Biomed. Pharmacother. 2018;103:699\u2013707. doi: 10.1016/j.biopha.2018.04.072.", "ArticleIdList": ["10.1016/j.biopha.2018.04.072", "29680738"]}, {"Citation": "Shukla S., Bhaskaran N., Babcook M.A., Fu P., Maclennan G.T., Gupta S. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis. 2014;35:452\u2013460. doi: 10.1093/carcin/bgt316.", "ArticleIdList": ["10.1093/carcin/bgt316", "PMC3983429", "24067903"]}, {"Citation": "Shukla S., Shankar E., Fu P., MacLennan G.T., Gupta S. Suppression of NF-\u03baB and NF-\u03baB-Regulated Gene Expression by Apigenin through I\u03baB\u03b1 and IKK Pathway in TRAMP Mice. PLoS ONE. 2015;10:e0138710.", "ArticleIdList": ["PMC4574560", "26379052"]}, {"Citation": "Chen M., Wang X., Zha D., Cai F., Zhang W., He Y., Huang Q., Zhuang H., Hua Z.C. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner. Sci. Rep. 2016;6:35468. doi: 10.1038/srep35468.", "ArticleIdList": ["10.1038/srep35468", "PMC5067669", "27752089"]}, {"Citation": "Shao H., Jing K., Mahmoud E., Huang H., Fang X., Yu C. Apigenin sensitizes colon cancer cells to antitumor activity of ABT-263. Mol. Cancer Ther. 2013;12:2640\u20132650. doi: 10.1158/1535-7163.MCT-13-0066.", "ArticleIdList": ["10.1158/1535-7163.MCT-13-0066", "PMC3871201", "24126433"]}, {"Citation": "Lim W., Park S., Bazer F.W., Song G. Apigenin Reduces Survival of Choriocarcinoma Cells by Inducing Apoptosis via the PI3K/AKT and ERK1/2 MAPK Pathways. J. Cell. Physiol. 2016;231:2690\u20132699. doi: 10.1002/jcp.25372.", "ArticleIdList": ["10.1002/jcp.25372", "26970256"]}, {"Citation": "Granato M., Gilardini Montani M.S., Santarelli R., D\u2019Orazi G., Faggioni A., Cirone M. Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death. J. Exp. Clin. Cancer Res. 2017;36:167. doi: 10.1186/s13046-017-0632-z.", "ArticleIdList": ["10.1186/s13046-017-0632-z", "PMC5704516", "29179721"]}, {"Citation": "Cao H.H., Chu J.H., Kwan H.Y., Su T., Yu H., Cheng C.Y., Fu X.Q., Guo H., Li T., Tse A.K., et al. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma. Sci. Rep. 2016;6:21731. doi: 10.1038/srep21731.", "ArticleIdList": ["10.1038/srep21731", "PMC4766576", "26911838"]}, {"Citation": "Hu W.J., Liu J., Zhong L.K., Wang J. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling. Biomed. Pharmacother. 2018;102:681\u2013688. doi: 10.1016/j.biopha.2018.03.111.", "ArticleIdList": ["10.1016/j.biopha.2018.03.111", "29604587"]}, {"Citation": "Xu M., Wang S., Song Y.U., Yao J., Huang K., Zhu X. Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/\u03b2-catenin signaling pathway. Oncol. Lett. 2016;11:3075\u20133080. doi: 10.3892/ol.2016.4331.", "ArticleIdList": ["10.3892/ol.2016.4331", "PMC4840993", "27123066"]}, {"Citation": "Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u2013444. doi: 10.1038/nature07205.", "ArticleIdList": ["10.1038/nature07205", "18650914"]}, {"Citation": "Grivennikov S.I., Karin M. Inflammation and oncogenesis: A vicious connection. Curr. Opin. Genet. Dev. 2010;20:65\u201371. doi: 10.1016/j.gde.2009.11.004.", "ArticleIdList": ["10.1016/j.gde.2009.11.004", "PMC2821983", "20036794"]}, {"Citation": "Bian Y., Liu P., Zhong J., Hu Y., Zhuang S., Fan K., Liu Z. Quercetin Attenuates Adhesion Molecule Expression in Intestinal Microvascular Endothelial Cells by Modulating Multiple Pathways. Dig. Dis Sci. 2018;63:3297\u20133304. doi: 10.1007/s10620-018-5221-2.", "ArticleIdList": ["10.1007/s10620-018-5221-2", "30076503"]}, {"Citation": "Hoensch H.P., Weigmann B. Regulation of the intestinal immune system by flavonoids and its utility in chronic inflammatory bowel disease. World J. Gastroenterol. 2018;24:877\u2013881. doi: 10.3748/wjg.v24.i8.877.", "ArticleIdList": ["10.3748/wjg.v24.i8.877", "PMC5829151", "29491681"]}, {"Citation": "Wang W., Liu X., Zhang Z., Yin M., Chen X., Zhao S., Wu L. Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma. Oxid Med Cell Longev. 2022;2022:8172866. doi: 10.1155/2022/8172866.", "ArticleIdList": ["10.1155/2022/8172866", "PMC9371852", "35965686"]}, {"Citation": "Yang C., Song J., Hwang S., Choi J., Song G., Lim W. Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells. Redox. Biol. 2021;47:102144. doi: 10.1016/j.redox.2021.102144.", "ArticleIdList": ["10.1016/j.redox.2021.102144", "PMC8476449", "34562873"]}, {"Citation": "Karmakar S., Davis K.A., Choudhury S.R., Deeconda A., Banik N.L., Ray S.K. Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways. Biochem. Biophys. Res. Commun. 2009;388:705\u2013710. doi: 10.1016/j.bbrc.2009.08.071.", "ArticleIdList": ["10.1016/j.bbrc.2009.08.071", "PMC3103942", "19695221"]}, {"Citation": "Wang I.K., Lin-Shiau S.Y., Lin J.K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer. 1999;35:1517\u20131525. doi: 10.1016/S0959-8049(99)00168-9.", "ArticleIdList": ["10.1016/S0959-8049(99)00168-9", "10673981"]}, {"Citation": "Jin X.Y., Ren C.S. [Effect and mechanism of apigenin on VEGF expression in human breast cancer cells] Zhonghua Zhong Liu Za Zhi. 2007;29:495\u2013499.", "ArticleIdList": ["18069627"]}, {"Citation": "Shukla S., Gupta S. Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol. Cancer Ther. 2006;5:843\u2013852. doi: 10.1158/1535-7163.MCT-05-0370.", "ArticleIdList": ["10.1158/1535-7163.MCT-05-0370", "16648554"]}, {"Citation": "Lee Y., Sung B., Kang Y.J., Kim D.H., Jang J.Y., Hwang S.Y., Kim M., Lim H.S., Yoon J.H., Chung H.Y., et al. Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells. Int. J. Oncol. 2014;44:1599\u20131606. doi: 10.3892/ijo.2014.2339.", "ArticleIdList": ["10.3892/ijo.2014.2339", "24626522"]}, {"Citation": "Adham A.N., Abdelfatah S., Naqishbandi A.M., Mahmoud N., Efferth T. Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells. Phytomedicine. 2021;80:153371. doi: 10.1016/j.phymed.2020.153371.", "ArticleIdList": ["10.1016/j.phymed.2020.153371", "33070080"]}, {"Citation": "Bao Y.Y., Zhou S.H., Lu Z.J., Fan J., Huang Y.P. Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo. Oncol. Rep. 2015;34:1805\u20131814. doi: 10.3892/or.2015.4158.", "ArticleIdList": ["10.3892/or.2015.4158", "26238658"]}, {"Citation": "Yu W., Sun H., Zha W., Cui W., Xu L., Min Q., Wu J. Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway. Evid. Based Complement. Alternat. Med. 2017;2017:2590676. doi: 10.1155/2017/2590676.", "ArticleIdList": ["10.1155/2017/2590676", "PMC5480054", "28684964"]}, {"Citation": "Liao Y., Shen W., Kong G., Lv H., Tao W., Bo P. Apigenin Induces the Apoptosis and Regulates MAPK Signaling Pathways in Mouse Macrophage ANA-1 Cells. PLoS ONE. 2014;9:e92007. doi: 10.1371/journal.pone.0092007.", "ArticleIdList": ["10.1371/journal.pone.0092007", "PMC3960135", "24646936"]}, {"Citation": "Shukla S., MacLennan G.T., Fu P., Gupta S. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model. Pharm. Res. 2012;29:1506\u20131517. doi: 10.1007/s11095-011-0625-0.", "ArticleIdList": ["10.1007/s11095-011-0625-0", "PMC4017263", "22139534"]}, {"Citation": "Jin G., Yang Y., Liu K., Zhao J., Chen X., Liu H., Bai R., Li X., Jiang Y., Zhang X. Combination curcumin and (\u2212)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway. Oncogenesis. 2017;6:e384. doi: 10.1038/oncsis.2017.84.", "ArticleIdList": ["10.1038/oncsis.2017.84", "PMC5668882", "28967875"]}, {"Citation": "Pensa S., Regis G., Boselli D., Novelli F., Poli V. STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin? In: Stephanou A., editor. JAK-STAT Pathway in Disease. Landes Bioscience; Austin, TX, USA: 2009. pp. 100\u2013121."}, {"Citation": "Su T., Huang C., Yang C., Jiang T., Su J., Chen M., Liu Z. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity. Pharmacol. Res. 2020;152:104586. doi: 10.1016/j.phrs.2019.104586.", "ArticleIdList": ["10.1016/j.phrs.2019.104586", "31877350"]}, {"Citation": "Chen Z., Tian D., Liao X., Zhang Y., Xiao J., Chen W., Liu Q., Chen Y., Li D., Zhu L., et al. Apigenin Combined with Gefitinib Blocks Autophagy Flux and Induces Apoptotic Cell Death Through Inhibition of HIF-1\u03b1, c-Myc, p-EGFR, and Glucose Metabolism in EGFR L858R+T790M-Mutated H1975 Cells. Front. Pharmacol. 2019;10:260. doi: 10.3389/fphar.2019.00260.", "ArticleIdList": ["10.3389/fphar.2019.00260", "PMC6438929", "30967777"]}, {"Citation": "Liu X., Li L., Lv L., Chen D., Shen L., Xie Z. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/\u03b2-catenin signaling pathway. Oncol. Rep. 2015;34:1035\u20131041. doi: 10.3892/or.2015.4022.", "ArticleIdList": ["10.3892/or.2015.4022", "26035210"]}, {"Citation": "Anwar S., Almatroudi A., Alsahli M.A., Khan M.A., Khan A.A., Rahmani A.H. Natural Products: Implication in Cancer Prevention and Treatment through Modulating Various Biological Activities. Anticancer Agents Med. Chem. 2020;20:2025\u20132040. doi: 10.2174/1871520620666200705220307.", "ArticleIdList": ["10.2174/1871520620666200705220307", "32628596"]}, {"Citation": "Almatroodi S.A., Almatroudi A., Alsahli M.A., Rahmani A.H. Fenugreek (Trigonella Foenum-Graecum) and its Active Compounds: A Review of its Effects on Human Health through Modulating Biological Activities. Pharmacog. J. 2021;13:813\u2013821. doi: 10.5530/pj.2021.13.103.", "ArticleIdList": ["10.5530/pj.2021.13.103"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Almatroudi A., Rahmani A.H. Garlic and its Active Compounds: A Potential Candidate in The Prevention of Cancer by Modulating Various Cell Signalling Pathways. Anticancer Agents Med. Chem. 2019;19:1314\u20131324. doi: 10.2174/1871520619666190409100955.", "ArticleIdList": ["10.2174/1871520619666190409100955", "30963982"]}, {"Citation": "Way T.D., Kao M.C., Lin J.K. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 2004;279:4479\u20134489. doi: 10.1074/jbc.M305529200.", "ArticleIdList": ["10.1074/jbc.M305529200", "14602723"]}, {"Citation": "Choi E.J., Kim G.H. Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells. J. Clin. Biochem. Nutr. 2009;44:260\u2013265. doi: 10.3164/jcbn.08-230.", "ArticleIdList": ["10.3164/jcbn.08-230", "PMC2675027", "19430615"]}, {"Citation": "Choi E.J., Kim G.H. 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells. Oncol. Rep. 2009;22:1533\u20131537. doi: 10.3892/or_00000598.", "ArticleIdList": ["10.3892/or_00000598", "19885610"]}, {"Citation": "Zheng P.W., Chiang L.C., Lin C.C. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci. 2005;76:1367\u20131379. doi: 10.1016/j.lfs.2004.08.023.", "ArticleIdList": ["10.1016/j.lfs.2004.08.023", "15670616"]}, {"Citation": "Czyz J., Madeja Z., Irmer U., Korohoda W., Hulser D.F. Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. Int. J. Cancer. 2005;114:12\u201318. doi: 10.1002/ijc.20620.", "ArticleIdList": ["10.1002/ijc.20620", "15523693"]}, {"Citation": "Li Z.D., Hu X.W., Wang Y.T., Fang J. Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1. FEBS Lett. 2009;583:1999\u20132003. doi: 10.1016/j.febslet.2009.05.013.", "ArticleIdList": ["10.1016/j.febslet.2009.05.013", "19447105"]}, {"Citation": "Ittiudomrak T., Puthong S., Roytrakul S., Chanchao C. \u03b1-Mangostin and Apigenin Induced Cell Cycle Arrest and Programmed Cell Death in SKOV-3 Ovarian Cancer Cells. Toxicol. Res. 2019;35:167\u2013179. doi: 10.5487/TR.2019.35.2.167.", "ArticleIdList": ["10.5487/TR.2019.35.2.167", "PMC6467359", "31015899"]}, {"Citation": "Tang A.Q., Cao X.C., Tian L., He L., Liu F. Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3-derived sphere-forming cells. Mol. Med. Rep. 2015;11:2221\u20132226. doi: 10.3892/mmr.2014.2974.", "ArticleIdList": ["10.3892/mmr.2014.2974", "25405327"]}, {"Citation": "ilardini Montani M.S., Cecere N., Granato M., Romeo M.A., Falcinelli L., Ciciarelli U., D\u2019Orazi G., Faggioni A., Cirone M. Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells. Cancers. 2019;11:703. doi: 10.3390/cancers11050703.", "ArticleIdList": ["10.3390/cancers11050703", "PMC6562395", "31121848"]}, {"Citation": "Ujiki M.B., Ding X.Z., Salabat M.R., Bentrem D.J., Golkar L., Milam B., Talamonti M.S., Bell R.H., Jr., Iwamura T., Adrian T.E. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol. Cancer. 2006;5:76. doi: 10.1186/1476-4598-5-76.", "ArticleIdList": ["10.1186/1476-4598-5-76", "PMC1779363", "17196098"]}, {"Citation": "Wu D.G., Yu P., Li J.W., Jiang P., Sun J., Wang H.Z., Zhang L.D., Wen M.B., Bie P. Apigenin potentiates the growth inhibitory effects by IKK-\u03b2-mediated NF-\u03baB activation in pancreatic cancer cells. Toxicol. Lett. 2014;224:157\u2013164. doi: 10.1016/j.toxlet.2013.10.007.", "ArticleIdList": ["10.1016/j.toxlet.2013.10.007", "24148603"]}, {"Citation": "Subhasitanont P., Chokchaichamnankit D., Chiablaem K., Keeratichamroen S., Ngiwsara L., Paricharttanakul N.M., Lirdprapamongkol K., Weeraphan C., Svasti J., Srisomsap C. Apigenin inhibits growth and induces apoptosis in human cholangiocarcinoma cells. Oncol. Lett. 2017;14:4361\u20134371. doi: 10.3892/ol.2017.6705.", "ArticleIdList": ["10.3892/ol.2017.6705", "PMC5604180", "28943950"]}, {"Citation": "Chen X., Xu H., Yu X., Wang X., Zhu X., Xu X. Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway. J. BUON. 2019;24:488\u2013493.", "ArticleIdList": ["31127995"]}, {"Citation": "Tong J., Shen Y., Zhang Z., Hu Y., Zhang X., Han L. Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-\u03baB/Snail signaling pathway. Biosci. Rep. 2019;39:BSR20190452. doi: 10.1042/BSR20190452.", "ArticleIdList": ["10.1042/BSR20190452", "PMC6522743", "30967496"]}, {"Citation": "Maeda Y., Takahashi H., Nakai N., Yanagita T., Ando N., Okubo T., Saito K., Shiga K., Hirokawa T., Hara M., et al. Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer. Int. J. Oncol. 2018;52:1661\u20131673. doi: 10.3892/ijo.2018.4308.", "ArticleIdList": ["10.3892/ijo.2018.4308", "29512707"]}, {"Citation": "Zhu Y., Mao Y., Chen H., Lin Y., Hu Z., Wu J., Xu X., Xu X., Qin J., Xie L. Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell Int. 2013;13:54. doi: 10.1186/1475-2867-13-54.", "ArticleIdList": ["10.1186/1475-2867-13-54", "PMC3674905", "23724790"]}, {"Citation": "Xia Y., Yuan M., Li S., Thuan U.T., Nguyen T.T., Kang T.W., Liao W., Lian S., Jung Y.D. Apigenin Suppresses the IL-1\u03b2-Induced Expression of the Urokinase-Type Plasminogen Activator Receptor by Inhibiting MAPK-Mediated AP-1 and NF-\u03baB Signaling in Human Bladder Cancer T24 Cells. J. Agric. Food. Chem. 2018;66:7663\u20137673. doi: 10.1021/acs.jafc.8b02351.", "ArticleIdList": ["10.1021/acs.jafc.8b02351", "29945448"]}, {"Citation": "Liu Q., Chen X., Yang G., Min X., Deng M. Apigenin inhibits cell migration through MAPK pathways in human bladder smooth muscle cells. Biocell. 2011;35:71\u201379. doi: 10.32604/biocell.2011.35.071.", "ArticleIdList": ["10.32604/biocell.2011.35.071", "22423483"]}, {"Citation": "Li Y., Cheng X., Chen C., Huijuan W., Zhao H., Liu W., Xiang Z., Wang Q. Apigenin, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1/CDK4 regulation via p38 MAPK-p21 signaling. Pathol. Res. Pract. 2020;216:152701. doi: 10.1016/j.prp.2019.152701.", "ArticleIdList": ["10.1016/j.prp.2019.152701", "31780054"]}, {"Citation": "Gao A.M., Zhang X.Y., Hu J.N., Ke Z.P. Apigenin sensitizes hepatocellular carcinoma cells to doxorubic through regulating miR-520b/ATG7 axis. Chem. Biol. Interact. 2018;280:45\u201350. doi: 10.1016/j.cbi.2017.11.020.", "ArticleIdList": ["10.1016/j.cbi.2017.11.020", "29191453"]}, {"Citation": "Singh J.P., Selvendiran K., Banu S.M., Padmavathi R., Sakthisekaran D. Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats. Phytomedicine. 2004;11:309\u2013314. doi: 10.1078/0944711041495254.", "ArticleIdList": ["10.1078/0944711041495254", "15185843"]}, {"Citation": "Zhu H., Jin H., Pi J., Bai H., Yang F., Wu C., Jiang J., Cai J. Apigenin induced apoptosis in esophageal carcinoma cells by destruction membrane structures. Scanning. 2016;38:322\u2013328. doi: 10.1002/sca.21273.", "ArticleIdList": ["10.1002/sca.21273", "26435325"]}, {"Citation": "Ketkaew Y., Osathanon T., Pavasant P., Sooampon S. Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line. Arch. Oral Biol. 2017;74:69\u201374. doi: 10.1016/j.archoralbio.2016.11.010.", "ArticleIdList": ["10.1016/j.archoralbio.2016.11.010", "27886571"]}, {"Citation": "Swanson H.I., Choi E.Y., Helton W.B., Gairola C.G., Valentino J. Impact of apigenin and kaempferol on human head and neck squamous cell carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2014;117:214\u2013220. doi: 10.1016/j.oooo.2013.10.012.", "ArticleIdList": ["10.1016/j.oooo.2013.10.012", "PMC3983952", "24439916"]}, {"Citation": "Maggioni D., Garavello W., Rigolio R., Pignataro L., Gaini R., Nicolini G. Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis. Int. J. Oncol. 2013;43:1675\u20131682. doi: 10.3892/ijo.2013.2072.", "ArticleIdList": ["10.3892/ijo.2013.2072", "23969487"]}, {"Citation": "Huang S., Yu M., Shi N., Zhou Y., Li F., Li X., Huang X., Jin J. Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro. J. Cancer. 2020;11:2123\u20132132. doi: 10.7150/jca.34981.", "ArticleIdList": ["10.7150/jca.34981", "PMC7052937", "32127939"]}, {"Citation": "Zhao G., Han X., Cheng W., Ni J., Zhang Y., Lin J., Song Z. Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells. Oncol. Rep. 2017;37:2277\u20132285. doi: 10.3892/or.2017.5450.", "ArticleIdList": ["10.3892/or.2017.5450", "28260058"]}, {"Citation": "Masuelli L., Benvenuto M., Mattera R., Di Stefano E., Zago E., Taffera G., Tresoldi I., Giganti M.G., Frajese G.V., Berardi G., et al. In Vitro and In Vivo Anti-tumoral Effects of the Flavonoid Apigenin in Malignant Mesothelioma. Front. Pharmacol. 2017;8:373. doi: 10.3389/fphar.2017.00373.", "ArticleIdList": ["10.3389/fphar.2017.00373", "PMC5474957", "28674496"]}, {"Citation": "Fang J., Bao Y., Zhou S., Fan J. Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1. Mol. Med. Rep. 2015;12:6461\u20136466. doi: 10.3892/mmr.2015.4233.", "ArticleIdList": ["10.3892/mmr.2015.4233", "PMC4626186", "26300442"]}, {"Citation": "Zhao M., Ma J., Zhu H., Zhang X., Du Z., Xu Y., Yu X. Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90. Mol. Cancer. 2011;10:104. doi: 10.1186/1476-4598-10-104.", "ArticleIdList": ["10.1186/1476-4598-10-104", "PMC3170639", "21871133"]}, {"Citation": "Ruela-de-Sousa R.R., Fuhler G.M., Blom N., Ferreira C.V., Aoyama H., Peppelenbosch M.P. Cytotoxicity of apigenin on leukemia cell lines: Implications for prevention and therapy. Cell Death Dis. 2010;1:e19. doi: 10.1038/cddis.2009.18.", "ArticleIdList": ["10.1038/cddis.2009.18", "PMC3032507", "21364620"]}, {"Citation": "Budhraja A., Gao N., Zhang Z., Son Y.O., Cheng S., Wang X., Ding S., Hitron A., Chen G., Luo J., et al. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol. Cancer Ther. 2012;11:132\u2013142. doi: 10.1158/1535-7163.MCT-11-0343.", "ArticleIdList": ["10.1158/1535-7163.MCT-11-0343", "PMC4430727", "22084167"]}, {"Citation": "Zhu Y., Wu J., Li S., Wang X., Liang Z., Xu X., Xu X., Hu Z., Lin Y., Chen H., et al. Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer. Mol. Med. Rep. 2015;11:1004\u20131008. doi: 10.3892/mmr.2014.2801.", "ArticleIdList": ["10.3892/mmr.2014.2801", "25351792"]}, {"Citation": "Ayyildiz A., Koc H., Turkekul K., Erdogan S. Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells. Exp Oncol. 2021;43:125\u2013134.", "ArticleIdList": ["34190523"]}, {"Citation": "Shukla S., Kanwal R., Shankar E., Datt M., Chance M.R., Fu P., MacLennan G.T., Gupta S. Apigenin blocks IKK\u03b1 activation and suppresses prostate cancer progression. Oncotarget. 2015;6:31216\u201331232. doi: 10.18632/oncotarget.5157.", "ArticleIdList": ["10.18632/oncotarget.5157", "PMC4741599", "26435478"]}, {"Citation": "Lin C.C., Chuang Y.J., Yu C.C., Yang J.S., Lu C.C., Chiang J.H., Lin J.P., Tang N.Y., Huang A.C., Chung J.G. Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo. J. Agric. Food Chem. 2012;60:11395\u201311402. doi: 10.1021/jf303446x.", "ArticleIdList": ["10.1021/jf303446x", "23066961"]}, {"Citation": "Kim S.H., Kang J.G., Kim C.S., Ihm S.H., Choi M.G., Yoo H.J., Lee S.J. Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells. Anticancer Res. 2015;35:6529\u20136537.", "ArticleIdList": ["26637867"]}, {"Citation": "Zhang L., Cheng X., Gao Y., Zheng J., Xu Q., Sun Y., Guan H., Yu H., Sun Z. Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells. Food Funct. 2015;6:3464\u20133472. doi: 10.1039/C5FO00671F.", "ArticleIdList": ["10.1039/C5FO00671F", "26292725"]}, {"Citation": "Kim B., Jung N., Lee S., Sohng J.K., Jung H.J. Apigenin Inhibits Cancer Stem Cell-Like Phenotypes in Human Glioblastoma Cells via Suppression of c-Met Signaling. Phytother. Res. 2016;30:1833\u20131840. doi: 10.1002/ptr.5689.", "ArticleIdList": ["10.1002/ptr.5689", "27468969"]}, {"Citation": "Wan Y., Fei X., Wang Z., Jiang D., Chen H., Wang M., Zhou S. miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway. Tumour Biol. 2017;39:1010428317695526. doi: 10.1177/1010428317695526.", "ArticleIdList": ["10.1177/1010428317695526", "28381178"]}, {"Citation": "Long X., Fan M., Bigsby R.M., Nephew K.P. Apigenin Inhibits Antiestrogen-resistant Breast Cancer Cell Growth through Estrogen Receptor-\u03b1-dependent and -independent Mechanisms. Mol. Cancer Ther. 2008;7:2096\u20132108. doi: 10.1158/1535-7163.MCT-07-2350.", "ArticleIdList": ["10.1158/1535-7163.MCT-07-2350", "PMC2559959", "18645020"]}, {"Citation": "Souza R.P., Bonfim-Mendon\u00e7a P.S., Gimenes F., Ratti B.A., Kaplum V., Bruschi M.L., Nakamura C.V., Silva S.O., Maria-Engler S.S., Consolaro M.E. Oxidative Stress Triggered by Apigenin Induces Apoptosis in a Comprehensive Panel of Human Cervical Cancer-Derived Cell Lines. Oxid. Med. Cell Longev. 2017;2017:1512745. doi: 10.1155/2017/1512745.", "ArticleIdList": ["10.1155/2017/1512745", "PMC5278229", "28191273"]}, {"Citation": "Zhang E., Zhang Y., Fan Z., Cheng L., Han S., Che H. Apigenin Inhibits Histamine-Induced Cervical Cancer Tumor Growth by Regulating Estrogen Receptor Expression. Molecules. 2020;25:1960. doi: 10.3390/molecules25081960.", "ArticleIdList": ["10.3390/molecules25081960", "PMC7221565", "32340124"]}, {"Citation": "Wu C., Chen F., Rushing J.W., Wang X., Kim H.J., Huang G., Haley-Zitlin V., He G. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines. J. Med. Food. 2006;9:55\u201361. doi: 10.1089/jmf.2006.9.55.", "ArticleIdList": ["10.1089/jmf.2006.9.55", "16579729"]}, {"Citation": "Qi Y., Ding Z., Yao Y., Ren F., Yin M., Yang S., Chen A. Apigenin induces apoptosis and counteracts cisplatin-induced chemoresistance via Mcl-1 in ovarian cancer cells. Exp. Med. 2020;20:1329\u20131336. doi: 10.3892/etm.2020.8880.", "ArticleIdList": ["10.3892/etm.2020.8880", "PMC7388300", "32742367"]}, {"Citation": "Liu M., Zhang Y., Xu Q., Liu G., Sun N., Che H., He T. Apigenin Inhibits the Histamine-Induced Proliferation of Ovarian Cancer Cells by Downregulating ER\u03b1/ER\u03b2 Expression. Front. Oncol. 2021;11:682917. doi: 10.3389/fonc.2021.682917.", "ArticleIdList": ["10.3389/fonc.2021.682917", "PMC8456091", "34568014"]}, {"Citation": "He J., Xu Q., Wang M., Li C., Qian X., Shi Z., Liu L.Z., Jiang B.H. Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model. Int. J. Mol. Sci. 2012;13:7271\u20137282. doi: 10.3390/ijms13067271.", "ArticleIdList": ["10.3390/ijms13067271", "PMC3397525", "22837693"]}, {"Citation": "Salabat M.R., Melstrom L.G., Strouch M.J., Ding X.Z., Milam B.M., Ujiki M.B., Chen C., Pelling J.C., Rao S., Grippo P.J., et al. Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines. Mol. Carcinog. 2008;47:835\u2013844. doi: 10.1002/mc.20441.", "ArticleIdList": ["10.1002/mc.20441", "18404646"]}, {"Citation": "Melstrom L.G., Salabat M.R., Ding X.Z., Milam B.M., Strouch M., Pelling J.C., Bentrem D.J. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells. Pancreas. 2008;37:426\u2013431. doi: 10.1097/MPA.0b013e3181735ccb.", "ArticleIdList": ["10.1097/MPA.0b013e3181735ccb", "18953257"]}, {"Citation": "Kuo C.H., Weng B.C., Wu C.C., Yang S.F., Wu D.C., Wang Y.C. Apigenin has anti-atrophic gastritis and anti-gastric cancer progression effects in Helicobacter pylori-infected Mongolian gerbils. J. Ethnopharmacol. 2014;151:1031\u20131039. doi: 10.1016/j.jep.2013.11.040.", "ArticleIdList": ["10.1016/j.jep.2013.11.040", "24374236"]}, {"Citation": "Wang Y.C., Huang K.M. In vitro anti-inflammatory effect of apigenin in the Helicobacter pylori-infected gastric adenocarcinoma cells. Food Chem. Toxicol. 2013;53:376\u2013383. doi: 10.1016/j.fct.2012.12.018.", "ArticleIdList": ["10.1016/j.fct.2012.12.018", "23266501"]}, {"Citation": "Shan S., Shi J., Yang P., Jia B., Wu H., Zhang X., Li Z. Apigenin Restrains Colon Cancer Cell Proliferation via Targeted Blocking of Pyruvate Kinase M2-Dependent Glycolysis. J. Agric. Food Chem. 2017;65:8136\u20138144. doi: 10.1021/acs.jafc.7b02757.", "ArticleIdList": ["10.1021/acs.jafc.7b02757", "28829588"]}, {"Citation": "Chung C.S., Jiang Y., Cheng D., Birt D.F. Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin. Mol. Carcinog. 2007;46:773\u2013782. doi: 10.1002/mc.20306.", "ArticleIdList": ["10.1002/mc.20306", "17620292"]}, {"Citation": "Shi M.D., Shiao C.K., Lee Y.C., Shih Y.W. Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis. Cancer Cell Int. 2015;15:33. doi: 10.1186/s12935-015-0186-0.", "ArticleIdList": ["10.1186/s12935-015-0186-0", "PMC4391114", "25859163"]}, {"Citation": "Huang C., Wei Y.X., Shen M.C., Tu Y.H., Wang C.C., Huang H.C. Chrysin, Abundant in morinda citrifolia fruit water-EtOAc extracts, combined with apigenin synergistically induced apoptosis and inhibited migration in human breast and liver cancer cells. J. Agric. Food Chem. 2016;64:4235\u20134245. doi: 10.1021/acs.jafc.6b00766.", "ArticleIdList": ["10.1021/acs.jafc.6b00766", "27137679"]}, {"Citation": "\u015eirin N., Elmas L., Se\u00e7me M., Dodurga Y. Investigation of possible effects of apigenin, sorafenib and combined applications on apoptosis and cell cycle in hepatocellular cancer cells. Gene. 2020;737:144428. doi: 10.1016/j.gene.2020.144428.", "ArticleIdList": ["10.1016/j.gene.2020.144428", "32045658"]}, {"Citation": "Qin Y., Zhao D., Zhou H.G., Wang X.H., Zhong W.L., Chen S., Gu W.G., Wang W., Zhang C.H., Liu Y.R., et al. Apigenin inhibits NF-\u03baB and snail signaling, EMT and metastasis in human hepatocellular carcinoma. Oncotarget. 2016;7:41421\u201341431. doi: 10.18632/oncotarget.9404.", "ArticleIdList": ["10.18632/oncotarget.9404", "PMC5173069", "27203387"]}, {"Citation": "Hu X.Y., Liang J.Y., Guo X.J., Liu L., Guo Y.B. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (\u0394\u03a8m)-mediated apoptosis in hepatocellular carcinoma. Clin. Exp. Pharm. Physiol. 2015;42:146\u2013153. doi: 10.1111/1440-1681.12333.", "ArticleIdList": ["10.1111/1440-1681.12333", "25363523"]}, {"Citation": "Qiu J.G., Wang L., Liu W.J., Wang J.F., Zhao E.J., Zhou F.M., Ji X.B., Wang L.H., Xia Z.K., Wang W., et al. Apigenin Inhibits IL-6 Transcription and Suppresses Esophageal Carcinogenesis. Front. Pharmacol. 2019;10:1002. doi: 10.3389/fphar.2019.01002.", "ArticleIdList": ["10.3389/fphar.2019.01002", "PMC6749068", "31572184"]}, {"Citation": "Masuelli L., Marzocchella L., Quaranta A., Palumbo C., Pompa G., Izzi V., Canini A., Modesti A., Galvano F., Bei R. Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling. Front. Biosci. (Landmark Ed.) 2011;16:1060\u20131068. doi: 10.2741/3735.", "ArticleIdList": ["10.2741/3735", "21196218"]}, {"Citation": "Zhang Y., Cao Y., Zhang L., Feng C., Zhou G., Wen G. Apigenin inhibits C5a-induced proliferation of human nasopharyngeal carcinoma cells through down-regulation of C5aR. Biosci. Rep. 2018;38:BSR20180456. doi: 10.1042/BSR20180456.", "ArticleIdList": ["10.1042/BSR20180456", "PMC6048209", "29685955"]}, {"Citation": "Li Y., Chen X., He W., Xia S., Jiang X., Li X., Bai J., Li N., Chen L., Yang B. Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells. Nutr. Cancer. 2020;73:1489\u20131497. doi: 10.1080/01635581.2020.1802494.", "ArticleIdList": ["10.1080/01635581.2020.1802494", "32757802"]}, {"Citation": "Lu H.F., Chie Y.J., Yang M.S., Lu K.W., Fu J.J., Yang J.S., Chen H.Y., Hsia T.C., Ma C.Y., Ip S.W., et al. Apigenin induces apoptosis in human lung cancer H460 cells through caspase- and mitochondria-dependent pathways. Hum. Exp. Toxicol. 2011;30:1053\u20131061. doi: 10.1177/0960327110386258.", "ArticleIdList": ["10.1177/0960327110386258", "20937639"]}, {"Citation": "Jiang Z.B., Wang W.J., Xu C., Xie Y.J., Wang X.R., Zhang Y.Z., Huang J.M., Huang M., Xie C., Liu P., et al. Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer. Cancer Lett. 2021;515:36\u201348. doi: 10.1016/j.canlet.2021.05.019.", "ArticleIdList": ["10.1016/j.canlet.2021.05.019", "34052328"]}, {"Citation": "Caltagirone S., Rossi C., Poggi A., Ranelletti F.O., Natali P.G., Brunetti M., Aiello F.B., Piantelli M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int. J. Cancer. 2000;87:595\u2013600. doi: 10.1002/1097-0215(20000815)87:4<595::AID-IJC21>3.0.CO;2-5.", "ArticleIdList": ["10.1002/1097-0215(20000815)87:4<595::AID-IJC21>3.0.CO;2-5", "10918203"]}, {"Citation": "Mohan N., Banik N.L., Ray S.K. Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells. Neurosci. Lett. 2011;502:24\u201329. doi: 10.1016/j.neulet.2011.07.016.", "ArticleIdList": ["10.1016/j.neulet.2011.07.016", "PMC3159706", "21801811"]}, {"Citation": "Shukla S., Gupta S. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radic. Biol. Med. 2008;44:1833\u20131845. doi: 10.1016/j.freeradbiomed.2008.02.007.", "ArticleIdList": ["10.1016/j.freeradbiomed.2008.02.007", "PMC2538676", "18342637"]}, {"Citation": "Shi Y., Lian K., Jia J. Apigenin Suppresses the Warburg Effect and Stem-like Properties in SOSP-9607 Cells by Inactivating the PI3K/Akt/mTOR Signaling Pathway. Evid.-Based Complement. Altern. Med. 2022;2022:1\u201310. doi: 10.1155/2022/3983637.", "ArticleIdList": ["10.1155/2022/3983637", "PMC8926538", "35310040"]}, {"Citation": "Hnit S.S.T., Yao M., Xie C., Bi L., Wong M., Liu T., de Souza P., Li Z., Dong Q. Apigenin impedes cell cycle progression at G2 phase in prostate cancer cells. Discov. Oncol. 2022;13:44. doi: 10.1007/s12672-022-00505-1.", "ArticleIdList": ["10.1007/s12672-022-00505-1", "PMC9174405", "35670862"]}, {"Citation": "D\u2019Amico E., Pierfelice T.V., Iezzi G., Di Pietro N., Lepore S., Lorusso F., Scarano A., Pandolfi A., Piattelli A., Petrini M. Apigenin Promotes Proliferation and Mineralization of Human Osteoblasts and Up-Regulates Osteogenic Markers. Appl. Sci. 2022;12:8510. doi: 10.3390/app12178510.", "ArticleIdList": ["10.3390/app12178510"]}, {"Citation": "Mabrouk Zayed M.M., Sahyon H.A., Hanafy N.A.N., El-Kemary M.A. The Effect of Encapsulated Apigenin Nanoparticles on HePG-2 Cells through Regulation of P53. Pharmaceutics. 2022;14:1160. doi: 10.3390/pharmaceutics14061160.", "ArticleIdList": ["10.3390/pharmaceutics14061160", "PMC9228521", "35745733"]}, {"Citation": "Mahbub A.A., Le Maitre C.L., Cross N.A., Jordan-Mahy N. The effect of apigenin and chemo-therapy combination treatments on apoptosis-related genes and proteins in acute leukae-mia cell lines. Sci. Rep. 2022;12:8858. doi: 10.1038/s41598-022-11441-z.", "ArticleIdList": ["10.1038/s41598-022-11441-z", "PMC9132959", "35614109"]}, {"Citation": "Janssen K.P., Mensink R.P., Cox F.J., Harryvan J.L., Hovenier R., Hollman P.C., Katan M.B. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study. Am. J. Clin. Nutr. 1998;67:255\u2013262. doi: 10.1093/ajcn/67.2.255.", "ArticleIdList": ["10.1093/ajcn/67.2.255", "9459373"]}, {"Citation": "De Font-Reaulx Rojas E., Dorazco-Barragan G. Clinical stabilisation in neurodegenerative diseases: Clinical study in phase II. Rev. Neurol. 2010;50:520\u2013528.", "ArticleIdList": ["20443170"]}, {"Citation": "Shoara R., Hashempur M.H., Ashraf A., Salehi A., Dehshahri S., Habibagahi Z. Efficacy and safety of topical Matricariachamomilla L. (chamomile) oil for knee osteoarthritis: A randomized con-trolled clinical trial. Complement. Ther. Clin. Pract. 2015;21:181\u2013187. doi: 10.1016/j.ctcp.2015.06.003.", "ArticleIdList": ["10.1016/j.ctcp.2015.06.003", "26256137"]}, {"Citation": "Ardalani H., Moghadam M.H., Rahimi R., Soltani J., Mozayanimonfared A., Moradi M., Azizi A. Sumac as a novel adjunctive treatment in hypertension: A randomized, double-blind, placebo-controlled clinical trial. RSC Adv. 2016;6:11507\u201311512. doi: 10.1039/C5RA22840A.", "ArticleIdList": ["10.1039/C5RA22840A"]}, {"Citation": "Zargaran A., Borhani-Haghighi A., Salehi-Marzijarani M., Faridi P., Daneshamouz S., Azadi A., Sadeghpour H., Sakhteman A., Mohagheghzadeh A. Evaluation of the effect of topical chamomile (Matricariachamomilla L.) oleogel as pain relief in migraine without aura: A randomized, double-blind, placebo-controlled, crossover study. Neurolsci. 2018;39:1345\u20131353.", "ArticleIdList": ["29808331"]}, {"Citation": "Xu Y., Xin Y., Diao Y., Lu C., Fu J., Luo L., Yin Z. Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells. PLoS ONE. 2011;6:e29169. doi: 10.1371/journal.pone.0029169.", "ArticleIdList": ["10.1371/journal.pone.0029169", "PMC3244456", "22216199"]}, {"Citation": "Chan L.P., Chou T.H., Ding H.Y., Chen P.R., Chiang F.Y., Kuo P.L., Liang C.H. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. Biochim. Biophys. Acta. 2012;1820:1081\u20131091. doi: 10.1016/j.bbagen.2012.04.013.", "ArticleIdList": ["10.1016/j.bbagen.2012.04.013", "22554915"]}, {"Citation": "Yang P.M., Chou C.J., Tseng S.H., Hung C.F. Bioinformatics and in vitro experimental analyses identify the selective therapeutic potential of interferon gamma and apigenin against cervical squamous cell carcinoma and adenocarcinoma. Oncotarget. 2017;8:46145\u201346162. doi: 10.18632/oncotarget.17574.", "ArticleIdList": ["10.18632/oncotarget.17574", "PMC5542256", "28526810"]}, {"Citation": "Choudhury D., Ganguli A., Dastidar D.G., Acharya B.R., Das A., Chakrabarti G. Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin. Biochimie. 2013;95:1297\u20131309. doi: 10.1016/j.biochi.2013.02.010.", "ArticleIdList": ["10.1016/j.biochi.2013.02.010", "23485682"]}, {"Citation": "Suh Y.A., Jo S.Y., Lee H.Y., Lee C. Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells. Int. J. Oncol. 2015;46:1405\u20131411. doi: 10.3892/ijo.2014.2808.", "ArticleIdList": ["10.3892/ijo.2014.2808", "25544427"]}, {"Citation": "Xu Y.Y., Wu T.T., Zhou S.H., Bao Y.Y., Wang Q.Y., Fan J., Huang Y.P. Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: An in vitro study. Int. J. Clin. Exp. Pathol. 2014;7:3938\u20133947.", "ArticleIdList": ["PMC4129005", "25120770"]}, {"Citation": "Johnson J.L., de Mejia E.G. Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro. Food Chem. Toxicol. 2013;60:83\u201391. doi: 10.1016/j.fct.2013.07.036.", "ArticleIdList": ["10.1016/j.fct.2013.07.036", "23871783"]}, {"Citation": "Mahbub A.A., Le Maitre C.L., Haywood-Small S.L., Cross N.A., Jordan-Mahy N. Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines. Cell Death Discov. 2015;1:15043. doi: 10.1038/cddiscovery.2015.43.", "ArticleIdList": ["10.1038/cddiscovery.2015.43", "PMC4979421", "27551472"]}, {"Citation": "Zhang X., Zhang W., Chen F., Lu Z. Combined effect of chrysin and apigenin on inhibiting the development and progression of colorectal cancer by suppressing the activity of P38-MAPK/AKT pathway. IUBMB Life. 2021;73:774\u2013783. doi: 10.1002/iub.2456.", "ArticleIdList": ["10.1002/iub.2456", "33625784"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Almatroudi A., Anwar S., Verma A.K., Dev K., Rahmani A.H. Cinnamon and its active compounds: A potential candidate in disease and tumour management through modulating various genes activity. Gene Rep. 2020;21:100966. doi: 10.1016/j.genrep.2020.100966.", "ArticleIdList": ["10.1016/j.genrep.2020.100966"]}, {"Citation": "Alsahli M.A., Anwar S., Alzahrani F.M., Almatroudi A., Alfheeaid H., Khan A.A., Allemailem K.S., Almatroodi S.A., Rahmani A.H. Health Promoting Effect of Phyllanthus emblica and Azadiractha indica against Advanced Glycation End Products Formation. Appl. Sci. 2021;11:8819. doi: 10.3390/app11198819.", "ArticleIdList": ["10.3390/app11198819"]}, {"Citation": "Anwar S., Almatroodi S.A., Almatroudi A., Allemailem K.S., Joseph R.J., Khan A.A., Alrumaihi F., Alsahli M.A., Rahmani A.H. Biosynthesis of silver nanoparticles using Tamarixarticulata leaf extract: An effective approach for attenuation of oxidative stress mediated diseases. Int. J. Food Prop. 2021;24:677\u2013701. doi: 10.1080/10942912.2021.1914083.", "ArticleIdList": ["10.1080/10942912.2021.1914083"]}, {"Citation": "Anwar S., Khan S., Almatroudi A., Khan A.A., AlSahli M.A., AlMatroodi S.A., Rahmani A.H. A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds. Mol. Biol. Rep. 2021;48:787\u2013805. doi: 10.1007/s11033-020-06084-0.", "ArticleIdList": ["10.1007/s11033-020-06084-0", "33389535"]}, {"Citation": "Currie G.M. Pharmacology, Part 2: Introduction to Pharmacokinetics. J. Nucl. Med. Technol. 2018;46:221\u2013230. doi: 10.2967/jnmt.117.199638.", "ArticleIdList": ["10.2967/jnmt.117.199638", "29724803"]}, {"Citation": "Herkenne C., Alberti I., Naik A., Kalia Y.N., Mathy F.X., Pr\u00e9at V., Guy R.H. In vivo methods for the assessment of topical drug bioavailability. Pharm. Res. 2008;25:87\u2013103. doi: 10.1007/s11095-007-9429-7.", "ArticleIdList": ["10.1007/s11095-007-9429-7", "PMC2217624", "17985216"]}, {"Citation": "Chow S.C. Bioavailability and Bioequivalence in Drug Development. Wiley Interdiscip. Rev. Comput. Stat. 2014;6:304\u2013312. doi: 10.1002/wics.1310.", "ArticleIdList": ["10.1002/wics.1310", "PMC4157693", "25215170"]}, {"Citation": "Darakhshan S., Pour A.B., Colagar A.H., Sisakhtnezhad S. Thymoquinone and its therapeutic potentials. Pharmacol. Res. 2015;95:138\u2013158. doi: 10.1016/j.phrs.2015.03.011.", "ArticleIdList": ["10.1016/j.phrs.2015.03.011", "25829334"]}, {"Citation": "Rein M.J., Renouf M., Cruz-Hernandez C., Actis-Goretta L., Thakkar S.K., da Pinto M. Bioavailability of bioactive food compounds: A challenging journey to bioefficacy. Br. J. Clin. Pharmacol. 2013;75:588\u2013602. doi: 10.1111/j.1365-2125.2012.04425.x.", "ArticleIdList": ["10.1111/j.1365-2125.2012.04425.x", "PMC3575927", "22897361"]}, {"Citation": "Erlund I., Kosonen T., Alfthan G., M\u00e4enp\u00e4\u00e4 J., Perttunen K., Kenraali J., Parantainen J., Aro A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. 2000;56:545\u2013553. doi: 10.1007/s002280000197.", "ArticleIdList": ["10.1007/s002280000197", "11151743"]}, {"Citation": "Ader P., Wessmann A., Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic. Biol. Med. 2000;28:1056\u20131067. doi: 10.1016/S0891-5849(00)00195-7.", "ArticleIdList": ["10.1016/S0891-5849(00)00195-7", "10832067"]}, {"Citation": "Graefe E.U., Derendorf H., Veit M. Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int. J. Clin. Pharmacol. Ther. 1999;37:219\u2013233.", "ArticleIdList": ["10363620"]}, {"Citation": "Crespy V., Morand C., Besson C., Manach C., Demigne C., Remesy C. Quercetin, but not Its Glycosides, Is Absorbed from the Rat Stomach. J. Agric. Food Chem. 2002;50:618\u2013621. doi: 10.1021/jf010919h.", "ArticleIdList": ["10.1021/jf010919h", "11804539"]}, {"Citation": "Nabavi S.M., Habtemariam S., Daglia M., Nabavi S.F. Apigenin and breast cancers: From chemistry to medicine. Anti-Cancer Agents Med. Chem. 2015;15:728\u2013735. doi: 10.2174/1871520615666150304120643.", "ArticleIdList": ["10.2174/1871520615666150304120643", "25738871"]}, {"Citation": "Zhang J., Liu D., Huang Y., Gao Y., Qian S. Biopharmaceutics classification and intestinal absorption study of apigenin. Int. J. Pharm. 2012;436:311\u2013317. doi: 10.1016/j.ijpharm.2012.07.002.", "ArticleIdList": ["10.1016/j.ijpharm.2012.07.002", "22796171"]}, {"Citation": "Salehi B., Venditti A., Sharifi-Rad M., Kregiel D., Sharifi-Rad J., Durazzo A., Lucarini M., Santini A., Souto E.B., Novellino E., et al. The Therapeutic Potential of Apigenin. Int. J. Mol. Sci. 2019;20:1305. doi: 10.3390/ijms20061305.", "ArticleIdList": ["10.3390/ijms20061305", "PMC6472148", "30875872"]}, {"Citation": "Gradolatto A., Basly J.P., Berges R., Teyssier C., Chagnon M.C., Siess M.H., Canivenc-Lavier M.C. Pharmacokinetics and Metabolism of Apigenin in Female and Male Rats after a Single Oral Administration. Drug Metab. Dispos. 2005;33:49\u201354. doi: 10.1124/dmd.104.000893.", "ArticleIdList": ["10.1124/dmd.104.000893", "15466493"]}, {"Citation": "Huang Y., Zhao X., Zu Y., Wang L., Deng Y., Wu M., Wang H. Enhanced Solubility and Bioavailability of Apigenin via Preparation of Solid Dispersions of Mesoporous Silica Nanoparticles. Iran. J. Pharm. Res. 2019;18:168\u2013182.", "ArticleIdList": ["PMC6487423", "31089353"]}, {"Citation": "Cao X., Liu B., Cao W., Zhang W., Zhang F., Zhao H., Meng R., Zhang L., Niu R., Hao X., et al. Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells. Chin. J. Cancer Res. 2013;25:212\u2013222.", "ArticleIdList": ["PMC3626985", "23592903"]}, {"Citation": "Yan X., Qi M., Li P., Zhan Y., Shao H. Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell Biosci. 2017;7:50. doi: 10.1186/s13578-017-0179-x.", "ArticleIdList": ["10.1186/s13578-017-0179-x", "PMC5629766", "29034071"]}, {"Citation": "Zhong L., Li Y., Xiong L., Wang W., Wu M., Yuan T., Yang W., Tian C., Miao Z., Wang T., et al. Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives. Signal Transduct. Target. 2021;6:201. doi: 10.1038/s41392-021-00572-w.", "ArticleIdList": ["10.1038/s41392-021-00572-w", "PMC8165101", "34054126"]}, {"Citation": "Mahalakshmi M., Sundaresan A., Balamurugan V. Molecular docking studies on apigenin as a target with mapk p38 for cardiovascular diseases. Int. J. Res. Dev. Pharm. Life Sci. 2016;5:2241\u20132244."}, {"Citation": "Saeed M., Kadioglu O., Khalid H., Sugimoto Y., Efferth T. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking. J Nutr Biochem. 2015;26:44\u201356. doi: 10.1016/j.jnutbio.2014.09.008.", "ArticleIdList": ["10.1016/j.jnutbio.2014.09.008", "25459885"]}, {"Citation": "Istifli E.S., Sarik\u00fcrkc\u00fc C. Assessment of apigenin-7-glucoside and luteolin-7-glucoside as multi-targeted agents against Alzheimer\u2019s disease: A molecular docking study. Int. J. Plant Based Pharm. 2021;1:56\u201364."}, {"Citation": "Nafisi S., Hashemi M., Rajabi M., Tajmir-Riahi H.A. DNA Adducts with Antioxidant Flavonoids: Morin, Apigenin, and Naringin. DNA Cell Biol. 2008;27:433\u2013442. doi: 10.1089/dna.2008.0735.", "ArticleIdList": ["10.1089/dna.2008.0735", "18491957"]}, {"Citation": "Adeoye A.O., Olanlokun J.O., Tijani H., Lawal S.O., Babarinde C.O., Akinwole M.T., Bewaji C.O. Molecular docking analysis of apigenin and quercetin from ethylacetate fraction of Adansoniadigitata with malaria-associated calcium transport protein: An in silico approach. Heliyon. 2019;5:e02248. doi: 10.1016/j.heliyon.2019.e02248.", "ArticleIdList": ["10.1016/j.heliyon.2019.e02248", "PMC6819832", "31687530"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "20"}, {"Year": "2022", "Month": "9", "Day": "9"}, {"Year": "2022", "Month": "9", "Day": "13"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "1", "Minute": "37"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["36144783", "PMC9505045", "10.3390/molecules27186051", "molecules27186051"]}}], "PubmedBookArticle": []}